key: cord-0730287-7gqljczz
authors: Kokkoris, S.; Papachatzakis, I.; Gavrielatou, E.; Ntaidou, T.; Ischaki, E.; Malachias, S.; Vrettou, C.; Nichlos, C.; Kanavou, A.; Zervakis, D.; Perivolioti, E.; Ranellou, K.; Argyropoulou, A.; Zakynthinos, S.; Kotanidou, A.; Routsi, C.
title: ICU-acquired blood stream infections in critically ill patients with coronavirus disease- 19()
date: 2020-11-18
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2020.11.009
sha: c223ad8f65483d29a46663ee1ad7eca93e077392
doc_id: 730287
cord_uid: 7gqljczz

nan

S. Kokkoris 1 , I. Papachatzakis 1 , E. Gavrielatou 1 , T. Ntaidou 1 , E. Ischaki 1 , S. Malachias 1 , C. 

In the context of the COVID-19 pandemic, information concerning secondary infections is so far scarce and variable. While a low rate has been reported in patients with COVID-19 during hospitalization [1] , this proportion increases in studies including intensive care unit (ICU) patients [2] . Furthermore, admission to ICUs with increased antimicrobial resistance is of concern. We investigated the incidence, etiology and impact of ICU-acquired infections in COVID-19 patients admitted to an ICU with a known burden of multidrug resistance [3] . We focused on blood stream infections (BSIs) because these represent definite infection events, whereas distinction between coloniazation and infection is more difficult with other specimen types.

The study included all patients with SARS-CoV-2 infection, confirmed by rt-PCR on nasopharyngeal swabs, consecutively admitted to the 28-bed COVID-ICU at "Evangelismos" Hospital, in Athens (Greece) between 19 th March and 20 th May 2020. Baseline clinical and laboratory data and illness severity, assessed by Sequential Organ Failure Assessment (SOFA) score, were recorded. ICU-acquired BSI was defined as a pathogen isolation from ≥1 blood specimen obtained at more than 48 hours after ICU admission. In patients with ≥2 BSIs only the first one was included, unless the subsequent episode was fungal. Comparisons between patients with and without BSI were performed by Mann-Whitney U test and Chi-square or Fisher's exact test, when appropriate. Data were expressed as median (IQR) or percentages.

Among 50 patients admitted during the study period, (median age 64 years, 76% male, 82% rate of mechanical ventilation, 72% at least one documented serious comorbidity), 20 (40%) had ≥1 episode of bacteraemia and 7 (14%) developed candidaemia. Overall, 50 episodes of ICU-acquired BSIs were registered (incidence 48 episodes per 1000 patient-ICU days).

Gram-negative pathogens predominated, including extensively-drug resistant and pan-drug BSI acquisition was associated with increased duration of mechanical ventilation and length of ICU stay compared to no-BSI acquisition: 33 (26) vs. 5 (11) and 38 (31) vs. 10 (7) days, respectively, p< 0.001). Candidemia was more frequent among patients with a previous BSI compared to those without (31.5% vs. 3.2%, p< 0.05). Survival time after the first episode of BSI in those patients who died was 19.5 (23) days. Crude ICU mortality was 32%, not significantly different between patients with and without BSIs (33% and 30%, respectively).

The observed incidence of 40% of bacterial BSIs is in contrast with that of 11.9% in New York City hospitals [4] as well as with an 8.1% of secondary infections in a meta-analysis [5] , both proportions reported on COVID-ICU patients. Nevertheless, it is comparable with subsequent findings showing an incidence of ICU-acquired infections up to 51.2%, including a BSI rate at 30.7% [2] ; also, with a reported increase in Gram-negative BSIs identified in COVID-ICUs [6] ; as well as with an estimated risk of 25% for BSI within 15 days after COVID-ICU admission [7] .

Notably, our study period represents the first COVID-19 pandemic wave. At that time our patients did not receive dexamethasone or other immunomodulatory agents. Unsurprisingly, microbiology and antimicrobial resistance patterns reflected our local ICU ecology, as previously reported [3] . In accordance, among COVID-19 patients, pathogens detected in hospital-acquired BSIs were similar to that of patients without COVID-19 in a recent study [8] . High workloads potentially may have contributed to increased rate in both BSIs and transmissions inside the ICU.

Although an increased mortality rate among COVID-19 patients with ICU-acquired BSI has been reported [6] , we did not find such an association. Highly supportive care and administration of synergistic combinations of antimicrobials in pan-drug resistant pathogens, may have contributed to this result. However, since clinical outcome in severe COVID-19 patients is multifactorial, no definite conclusion can be reached.

In summary, among COVID-19 patients we observed an increased incidence of ICUacquired BSIs, mostly due to multidrug-resistant pathogens. BSI development was associated with prolonged duration of mechanical ventilation and ICU stay, though without difference in clinical outcome. Infection control and stewardship strategies to prevent dissemination of multidrug resistance are needed. A polymicrobial population (one strain of Candida and one strain of Gram-negative bacterium) simultaneously grown by the same blood culture in one patient is shown with both colours.

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19

De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock

Clinical characteristics of Covid-19 in New York City

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Severe OVID-19 and healthcare-associated infections on the ICU: time to remember the basics?

Blood stream infections in critically ill patients with COVID-19

Predominance of hospital-acquired blood stream infection in patients with Covid-19 pneumonia

The authors wish to thank Professor George Ganos for developing the Figure and all ICU staff for their hard work during the pandemic.